Figure EV4. Treatment with ⍺‐TREM1 has no significant effect on FOXM1 and citH3 in nondiabetic wounds.

Representative pictures of vehicle (IgG isotype control) and ⍺‐TREM1‐treated nondiabetic wounds at day 4 show basal keratin marker K5, and neutrophil marker Ly6G, FOXM1, and citH3. Treatment of wounds with ⍺‐TREM1 resulted in no significant differences in FOXM1⁺ and citH3⁺ neutrophils compared to vehicle‐treated wounds. (Scale bar: 50 μm). Quantification of mean fluorescence intensity was performed with Fiji software. n = 3 wounds per group. Data presented as mean ± SD (two‐tailed unpaired Student's t‐test).